GLP-1 and Insulin: The Glucose-Dependent Mechanism That Protects You From Hypoglycemia
GLP-1 receptor agonists stimulate insulin only when blood glucose is elevated — a built-in safety mechanism against hypoglycemia. Here’s why non-diabetic monotherapy users face low risk, with the mechanism to back it up.